<HashMap><database>GEO</database><file_versions><headers><Content-Type>application/xml</Content-Type></headers><body><files><Other>ftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE231nnn/GSE231531/</Other></files><type>primary</type></body><statusCode>OK</statusCode><statusCodeValue>200</statusCodeValue></file_versions><scores/><additional><omics_type>Transcriptomics</omics_type><species>Mus musculus</species><gds_type>Expression profiling by high throughput sequencing</gds_type><full_dataset_link>https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE231531</full_dataset_link><repository>GEO</repository><entry_type>GSE</entry_type></additional><is_claimable>false</is_claimable><name>Up-regulation of cholesterol synthesis pathways and neurodegeneration in a knock-in Sod1 mutant mouse model of ALS.</name><description>Amyotrophic lateral sclerosis (ALS) is a severe neurodegenerative disorder affecting brain and spinal cord motor neurons. Mutations in the copper/zinc superoxide dismutase gene (SOD1) are associated with ~20% of inherited and 1-2% of sporadic ALS cases. Much has been learned from mice expressing transgenic copies of mutant SOD1, which typically involve high-level transgene expression, thereby differing from ALS patients expressing one mutant gene copy. We created a knock-in point mutation in the endogenous mouse Sod1 gene leading to mutant SOD1G85R protein expression, a human ALS-causing mutation, to generate a model that more closely represents patient gene expression. Heterozygous Sod1G85R mutant mice resemble wild type, whereas homozygous mutants have reduced body weight and lifespan, a mild neurodegenerative phenotype, and express very low mutant SOD1 protein levels with no detectable SOD1 activity. Homozygous mutants exhibit partial neuromuscular junction denervation at 3-4 months of age. Spinal cord motor neuron transcriptome analyses of homozygous Sod1G85R mice revealed up-regulation of cholesterol synthesis pathway genes compared to wild type. Transcriptome and phenotypic features of these mice are similar to Sod1 knock-out mice, suggesting the Sod1G85R phenotype is largely driven by loss of SOD1 function. By contrast, cholesterol synthesis genes are down-regulated in severely affected human TgSOD1G93A transgenic mice at 4 months. Our analyses implicate dysregulation of cholesterol or related lipid pathway genes in ALS pathogenesis. The Sod1G85R knock-in mouse is a useful ALS model to examine the importance of SOD1 activity in control of cholesterol homeostasis and motor neuron survival.</description><dates><publication>2026/05/01</publication></dates><accession>GSE231531</accession><cross_references><GSM>GSM7287780</GSM><GSM>GSM7287781</GSM><GSM>GSM7287782</GSM><GSM>GSM7287783</GSM><GSM>GSM7287784</GSM><GSM>GSM7287785</GSM><GSM>GSM7287786</GSM><GSM>GSM7287787</GSM><GSM>GSM7287788</GSM><GSM>GSM7287789</GSM><GSM>GSM7287800</GSM><GSM>GSM7287801</GSM><GSM>GSM7287802</GSM><GSM>GSM7287803</GSM><GSM>GSM7287804</GSM><GSM>GSM7287805</GSM><GSM>GSM7287806</GSM><GSM>GSM7287807</GSM><GSM>GSM7287808</GSM><GSM>GSM7287809</GSM><GSM>GSM7287790</GSM><GSM>GSM7287791</GSM><GSM>GSM7287792</GSM><GSM>GSM7287770</GSM><GSM>GSM7287793</GSM><GSM>GSM7287771</GSM><GSM>GSM7287772</GSM><GSM>GSM7287794</GSM><GSM>GSM7287795</GSM><GSM>GSM7287773</GSM><GSM>GSM7287796</GSM><GSM>GSM7287774</GSM><GSM>GSM7287775</GSM><GSM>GSM7287797</GSM><GSM>GSM7287798</GSM><GSM>GSM7287776</GSM><GSM>GSM7287810</GSM><GSM>GSM7287799</GSM><GSM>GSM7287777</GSM><GSM>GSM7287778</GSM><GSM>GSM7287811</GSM><GSM>GSM7287812</GSM><GSM>GSM7287779</GSM><GSM>GSM7287813</GSM><GPL>24247</GPL><GSE>231531</GSE><taxon>Mus musculus</taxon></cross_references></HashMap>